Enteric Softgel Capsules Market Report 2026

Enteric Softgel Capsules Market Overview

• Enteric Softgel Capsules market size has reached to $2.44 billion in 2025 • Expected to grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Rising Incidence Of Nutrition Disorders Driving Growth In The Enteric Softgel Capsules Market • Market Trend: Adoption Of Plant-Based Enteric Softgel Systems To Improve Acid-Resistant Delivery • North America was the largest region in 2025.

What Is Covered Under Enteric Softgel Capsules Market?

Enteric softgel capsules are designed to have a protective coating that shields their contents from stomach acid, allowing them to dissolve in the small intestine for targeted release and absorption. This technology is commonly used for probiotics, fish oil, and medications to safeguard sensitive ingredients or reduce stomach irritation. The main types of enteric softgel capsules are gelatin capsules and non-gelatin softgel capsules. Gelatin capsules are small, soluble containers made from gelatin, used to encase powdered or liquid substances for oral consumption. It is distributed through supermarkets and hypermarkets, pharmacies and drug stores, and online stores. The various types of applications include antacid and antiflatulent preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold preparations, health supplements, vitamin and dietary supplements, and other therapeutic applications. Catering to various end users such as pharmaceutical companies, nutraceutical companies, cosmeceutical companies, and the food industry

What Is The Enteric Softgel Capsules Market Growth Forecast?

The enteric softgel capsules market size is expected to see steady growth in the next few years. It will grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to vegan capsule demand, personalized nutrition growth, controlled-release formulation development, pharmaceutical outsourcing expansion, preventive healthcare focus. Major trends in the forecast period include rising demand for targeted drug delivery, growth in nutraceutical consumption, increased use of acid-resistant formulations, expansion of plant-based capsule adoption, focus on improved bioavailability.

Global Enteric Softgel Capsules Market Segmentation

1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules 2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores 3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications 4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry Subsegments: 1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules 2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

What Is The Driver Of The Enteric Softgel Capsules Market?

The increasing incidence of nutrition disorders is expected to propel the growth of the enteric softgel capsules market going forward. Nutritional disorders refer to conditions caused by imbalances in nutrient intake, either through deficiencies or excesses of essential vitamins, minerals, proteins, fats, and carbohydrates. The increasing incidence of nutrition disorders is driven by factors such as poor dietary habits, sedentary lifestyles, limited access to nutritious food, rising processed food consumption, and socio-economic challenges that hinder proper nutrition. Enteric softgel capsules help manage nutrition disorders by delivering essential nutrients in a way that protects them from stomach acid, ensuring targeted release in the intestines where absorption is most effective, thereby improving nutrient bioavailability and supporting overall digestive health and nutritional balance. For instance, in 2024, according to a report published by the Food and Agriculture Organization, a Canada-based specialized agency, in 2023, global undernourishment remained at 9.1 percent. Further, food insecurity affected 11.5 percent of the population in 2023. Therefore, the increasing incidence of nutrition disorders is driving the growth of the enteric softgel capsules industry.

Key Players In The Global Enteric Softgel Capsules Market

Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

Global Enteric Softgel Capsules Market Trends and Insights

Major companies are operating in the enteric softgel capsules market, focusing on developing technological advancements such as plant-based softgel excipient systems for acid-resistant intestinal release to enhance stability, improve bioavailability, and support clean-label, vegan formulations. A plant-based softgel excipient system uses non-animal-derived polymers, such as hydroxypropyl pea starch, to form shells that resist stomach acid and release active ingredients in the intestine, unlike traditional gelatin softgels that may dissolve in the stomach and degrade acid-sensitive actives. For instance, in April 2024, Roquette, a France-based plant-based ingredient supplier, launched LYCAGEL, a hydroxypropyl pea starch excipient for plant-based softgels. The product allows manufacturers to create vegan, clean-label softgels with acid-resistant functionality, protecting sensitive nutraceuticals such as omega-3s and probiotics, improving bioavailability, and eliminating the need for gelatin.

What Are Latest Mergers And Acquisitions In The Enteric Softgel Capsules Market?

In August 2024, Kühne Holding AG, a Switzerland-based transportation and logistics company, acquired Aenova Group GmbH from BC Partners for an undisclosed amount. Through this acquisition, Kühne Holding AG aims to enhance its investment portfolio by incorporating healthcare and pharmaceutical assets, which are expected to yield strong financial returns and long-term growth opportunities. Aenova Group GmbH is a Germany-based company that specializes in the end-to-end production of various dosage forms, including tablets, capsules, and sterile liquids.

Regional Outlook

North America was the largest region in the enteric softgel capsules market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Enteric Softgel Capsules Market?

The enteric softgel capsules market consists of sales of products including probiotics, pain relievers, digestive enzymes, and vitamins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Enteric Softgel Capsules Market Report 2026?

The enteric softgel capsules market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enteric softgel capsules industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.